Mark Cuban Foundation and CSL Bring AI Bootcamp to Philadelphia Teens

PHILADELPHIA, April 30, 2024 (GLOBE NEWSWIRE) -- The Mark Cuban Foundation, in partnership with CSL, is bringing the only artificial intelligence (AI) camp of its kind, free of charge, to high school students in Philadelphia. With a custom and highly-relevant curriculum focused on teaching students about the latest developments in the world of AI and Generative AI, the camp will provide the tools to make these technologies work for them and promises to educate, inspire and fuel the next generation of AI professionals.

These AI bootcamps are introductory and accessible to student in grades 9-12 with an interest in technology. Students do not need any familiarity with computer science or programming to attend. Over the course of three half-days, students will learn what AI is and isn't, where they already interact with AI in their own lives, the ethical implications of AI systems, and much more. Students also learn how to utilize ChatGPT via tailored inputs and use Microsoft's cloud computing tools to build their own AI applications.

“As AI continues to become an undeniable force in all of our lives, it’s crucial that we open the door to this knowledge, especially to young people who want to explore it,” said Mark Cuban, founder. “While technology expands and becomes more advanced,  it becomes more critical that we ensure our students are prepared when they apply for schools or jobs in the future. Thanks to our work with CSL, the bootcamp will offer an avenue to explore this fascinating field of technology to any student, no matter their means.”

This year’s bootcamp, taking place in Philadelphia on November 2nd, 9th, and 16th is hosted and staffed by CSL. CSL is a global biotechnology leader that develops and delivers innovative lifesaving medicines, protects public health and helps people with life-threatening medical conditions live full lives.

CSL is one of 25+ host companies selected to host camps across the US.

“CSL is proud to continue its partnership with the AI Bootcamp for the fourth year in a row, recognizing the significant role it plays in equipping the next generation for success in a continuously evolving industry,” said Mark Hill, CSL Chief Digital Information Officer. “This initiative is inclusive of all students and aims to foster curiosity and enthusiasm, providing them with practical experience in utilizing cutting-edge AI tools that are also under exploration within our enterprise.”

Applications for the bootcamp are now open at: markcubanai.org

Watch Mark Cuban’s message about Mark Cuban Foundation’s AI bootcamps and access the full media kit here.

To learn more, visit markcubanai.org.

Media contact:
Bishop.wash@markcubanai.org
thomas.hushen@cslbehring.com 

This bootcamp is facilitated with support from Mark Cuban Foundation AI Bootcamp Program's media partner, Notified, a globally trusted technology partner for investor relations, public relations and marketing professionals.

About Mark Cuban Foundation’s AI Bootcamp Initiative
The Mark Cuban Foundation is a 501(c)(3) private non-profit led by entrepreneur and investor Mark Cuban. The AI Bootcamps Program at MCF seeks to inspire young people with emerging technology so that they can create more equitable futures for themselves and their communities. Over 3 consecutive Saturdays underserved 9th-12th grade students learn what AI is and isn't, where they already interact with AI in their own lives, the ethical implications of AI systems, and much more. Learn more about the no-cost AI Bootcamp program at markcubanai.org.

About CSL
CSL (ASX:CSL; USOTC:CSLLY) is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses: CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. For inspiring stories about the promise of biotechnology, visit CSLBehring.com/Vita and follow us on Twitter.com/CSL. For more information about CSL, visit www.CSL.com.